Literature DB >> 20932759

4,5-Dihydro-1H-pyrazolo[4,3-h]quinazolines as potent and selective Polo-like kinase 1 (PLK1) inhibitors.

Italo Beria1, Barbara Valsasina, Maria Gabriella Brasca, Walter Ceccarelli, Maristella Colombo, Sabrina Cribioli, Gabriele Fachin, Ronald D Ferguson, Francesco Fiorentini, Laura M Gianellini, Maria L Giorgini, Jurgen K Moll, Helena Posteri, Daniele Pezzetta, Fulvia Roletto, Francesco Sola, Dania Tesei, Michele Caruso.   

Abstract

A series of 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivatives was optimized as Polo-like kinase 1 inhibitors. Extensive SAR afforded a highly potent and selective PLK1 compound. The compound showed good antiproliferative activity when tested in a panel of tumor cell lines with PLK1 related mechanism of action and with good in vivo antitumor efficacy in two xenograft models after i.v. administration.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20932759     DOI: 10.1016/j.bmcl.2010.09.060

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

Review 1.  In depth analysis of kinase cross screening data to identify chemical starting points for inhibition of the Nek family of kinases.

Authors:  C I Wells; N R Kapadia; R M Couñago; D H Drewry
Journal:  Medchemcomm       Date:  2017-12-08       Impact factor: 3.597

2.  Synthesis of Trifluoromethoxylated (Hetero)Arenes via OCF3 Migration.

Authors:  Katarzyna N Lee; Johnny W Lee; Ming-Yu Ngai
Journal:  Synlett       Date:  2015-11-16       Impact factor: 2.454

Review 3.  Applications of Palladium-Catalyzed C-N Cross-Coupling Reactions.

Authors:  Paula Ruiz-Castillo; Stephen L Buchwald
Journal:  Chem Rev       Date:  2016-09-30       Impact factor: 60.622

4.  Mechanistic studies on intramolecular C-H trifluoromethoxylation of (hetero)arenes via OCF3-migration.

Authors:  Katarzyna N Lee; Zhen Lei; Cristian A Morales-Rivera; Peng Liu; Ming-Yu Ngai
Journal:  Org Biomol Chem       Date:  2016-06-15       Impact factor: 3.876

5.  Combined pharmacophore modeling, docking, and 3D-QSAR studies of PLK1 inhibitors.

Authors:  Shuai Lu; Hai-Chun Liu; Ya-Dong Chen; Hao-Liang Yuan; Shan-Liang Sun; Yi-Ping Gao; Pei Yang; Liang Zhang; Tao Lu
Journal:  Int J Mol Sci       Date:  2011-12-01       Impact factor: 5.923

6.  Identification and antitumor activity of a novel inhibitor of the NIMA-related kinase NEK6.

Authors:  Marta De Donato; Benedetta Righino; Flavia Filippetti; Alessandra Battaglia; Marco Petrillo; Davide Pirolli; Giovanni Scambia; Maria Cristina De Rosa; Daniela Gallo
Journal:  Sci Rep       Date:  2018-10-30       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.